Last reviewed · How we verify
one dose of Influenza Vaccine
one dose of Influenza Vaccine is a Biologic drug developed by Beijing Chaoyang District Centre for Disease Control and Prevention. It is currently in Phase 1 development.
At a glance
| Generic name | one dose of Influenza Vaccine |
|---|---|
| Sponsor | Beijing Chaoyang District Centre for Disease Control and Prevention |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above (PHASE2)
- A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control (PHASE3)
- pH1N1 Blinded Challenge Study (PHASE1)
- Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults (PHASE1)
- Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women (PHASE3)
- High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients (PHASE2)
- Systems Biological Assessment of Statin Effect on Vaccine Responses (PHASE4)
- Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- one dose of Influenza Vaccine CI brief — competitive landscape report
- one dose of Influenza Vaccine updates RSS · CI watch RSS
- Beijing Chaoyang District Centre for Disease Control and Prevention portfolio CI
Frequently asked questions about one dose of Influenza Vaccine
What is one dose of Influenza Vaccine?
one dose of Influenza Vaccine is a Biologic drug developed by Beijing Chaoyang District Centre for Disease Control and Prevention.
Who makes one dose of Influenza Vaccine?
one dose of Influenza Vaccine is developed by Beijing Chaoyang District Centre for Disease Control and Prevention (see full Beijing Chaoyang District Centre for Disease Control and Prevention pipeline at /company/beijing-chaoyang-district-centre-for-disease-control-and-prevention).
What development phase is one dose of Influenza Vaccine in?
one dose of Influenza Vaccine is in Phase 1.